🎉 M&A multiples are live!
Check it out!

AmorePacific Valuation Multiples

Discover revenue and EBITDA valuation multiples for AmorePacific and similar public comparables like Sarantis Group, Lavipharm, and EZZ Life Science.

AmorePacific Overview

About AmorePacific

AmorePacific Corp is a Korean beauty, household, and healthcare goods producer. The product categories are moisturizer, eye care, serum and ampoule, cushion and coverage, cleanser, toner and fluid, masque, sun care, and special care. Its most well-known brands are AmorePacific, Sulwhasoo, Laneige, and Etude House. Most of the firm's revenue is generated in Korea, followed by China, Europe, and North America. The company has research centers not only in Korea, but also internationally in countries such as France, Japan, and China.


Founded

2006

HQ

South Korea
Employees

n/a

Website

apgroup.com

Sectors

Health & Beauty

Financials

LTM Revenue $2.9B

LTM EBITDA $433M

EV

$4.7B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

AmorePacific Financials

As of September 2025, AmorePacific reported last 12-month revenue of $2.9B and EBITDA of $433M.

In the same period, AmorePacific generated $2.1B in LTM gross profit and $256M in net income.

See AmorePacific valuation multiples based on analyst estimates

AmorePacific P&L

In the most recent fiscal year, AmorePacific reported revenue of $2.7B and EBITDA of $634M.

AmorePacific expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See AmorePacific valuation multiples based on analyst estimates
LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue $2.9B XXX $2.7B XXX XXX XXX
Gross Profit $2.1B XXX $1.9B XXX XXX XXX
Gross Margin 72% XXX 71% XXX XXX XXX
EBITDA $433M XXX $634M XXX XXX XXX
EBITDA Margin 15% XXX 23% XXX XXX XXX
EBIT $250M XXX $154M XXX XXX XXX
EBIT Margin 9% XXX 6% XXX XXX XXX
Net Profit $256M XXX $415M XXX XXX XXX
Net Margin 9% XXX 15% XXX XXX XXX
Net Debt XXX XXX n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

AmorePacific Stock Performance

AmorePacific has current market cap of KRW 7.29T (or $5.1B), and EV of KRW 6.70T (or $4.7B).

Market Cap Evolution

AmorePacific Stock Data

As of October 17, 2025, AmorePacific's stock price is KRW 105670 (or $74).

See AmorePacific trading valuation data
EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$4.7B $5.1B XXX XXX XXX XXX $4.04

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

AmorePacific Valuation Multiples

AmorePacific's trades at 1.7x EV/Revenue multiple, and 7.4x EV/EBITDA.

See valuation multiples for AmorePacific and 15K+ public comps

AmorePacific Financial Valuation Multiples

As of October 17, 2025, AmorePacific has market cap of $5.1B and EV of $4.7B.

Equity research analysts estimate AmorePacific's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

AmorePacific has a P/E ratio of 20.0x.

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Market cap (current) $5.1B XXX $5.1B XXX XXX XXX
EV (current) $4.7B XXX $4.7B XXX XXX XXX
EV/Revenue 1.6x XXX 1.7x XXX XXX XXX
EV/EBITDA 10.8x XXX 7.4x XXX XXX XXX
EV/EBIT 18.7x XXX 30.4x XXX XXX XXX
EV/Gross Profit 2.2x XXX n/a XXX XXX XXX
P/E 20.0x XXX 12.3x XXX XXX XXX
EV/FCF 15.1x XXX 29.3x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get AmorePacific Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

AmorePacific Margins & Growth Rates

AmorePacific's last 12 month revenue growth is 9%

AmorePacific's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.

AmorePacific's rule of 40 is 24% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

AmorePacific's rule of X is 37% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for AmorePacific and other 15K+ public comps

AmorePacific Operational Valuation Multiples

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue Growth 9% XXX 9% XXX XXX XXX
EBITDA Margin 15% XXX 23% XXX XXX XXX
EBITDA Growth 13% XXX 9% XXX XXX XXX
Rule of 40 24% XXX 32% XXX XXX XXX
Bessemer Rule of X XXX XXX 37% XXX XXX XXX
Revenue per Employee XXX XXX n/a XXX XXX XXX
Opex per Employee XXX XXX n/a XXX XXX XXX
S&M Expenses to Revenue XXX XXX 37% XXX XXX XXX
G&A Expenses to Revenue XXX XXX n/a XXX XXX XXX
R&D Expenses to Revenue XXX XXX 3% XXX XXX XXX
Opex to Revenue XXX XXX 65% XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

AmorePacific Public Comps

See public comps and valuation multiples for Health & Beauty comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Acme United XXX XXX XXX XXX XXX XXX
EZZ Life Science XXX XXX XXX XXX XXX XXX
Lavipharm XXX XXX XXX XXX XXX XXX
Sarantis Group XXX XXX XXX XXX XXX XXX
SynBiotic XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

AmorePacific M&A and Investment Activity

AmorePacific acquired  XXX companies to date.

Last acquisition by AmorePacific was  XXXXXXXX, XXXXX XXXXX XXXXXX . AmorePacific acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by AmorePacific

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.

Start Free Trial

About AmorePacific

When was AmorePacific founded? AmorePacific was founded in 2006.
Where is AmorePacific headquartered? AmorePacific is headquartered in South Korea.
Who is the CEO of AmorePacific? AmorePacific's CEO is Mr. Kyung-Bae Seo.
Is AmorePacific publicy listed? Yes, AmorePacific is a public company listed on KRX.
What is the stock symbol of AmorePacific? AmorePacific trades under 090430 ticker.
When did AmorePacific go public? AmorePacific went public in 2006.
Who are competitors of AmorePacific? Similar companies to AmorePacific include e.g. Acme United, EZZ Life Science, Lavipharm, Sarantis Group.
What is the current market cap of AmorePacific? AmorePacific's current market cap is $5.1B
What is the current revenue of AmorePacific? AmorePacific's last 12 months revenue is $2.9B.
What is the current revenue growth of AmorePacific? AmorePacific revenue growth (NTM/LTM) is 9%.
What is the current EV/Revenue multiple of AmorePacific? Current revenue multiple of AmorePacific is 1.6x.
Is AmorePacific profitable? Yes, AmorePacific is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of AmorePacific? AmorePacific's last 12 months EBITDA is $433M.
What is AmorePacific's EBITDA margin? AmorePacific's last 12 months EBITDA margin is 15%.
What is the current EV/EBITDA multiple of AmorePacific? Current EBITDA multiple of AmorePacific is 10.8x.
What is the current FCF of AmorePacific? AmorePacific's last 12 months FCF is $311M.
What is AmorePacific's FCF margin? AmorePacific's last 12 months FCF margin is 11%.
What is the current EV/FCF multiple of AmorePacific? Current FCF multiple of AmorePacific is 15.1x.

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.